title: [Dental avulsions and blood coagulation disorders].
abstract: BACKGROUND
  We performed a retrospective study of tooth removal for patients with coagulation disorders.
  
  
  METHODS
  The study included 67 patients divided into 3 groups according to their coagulation disorder. The first group included 31 patients with a congenital disorder, the second 19 patients receiving anticoagulant therapy, and the third 16 patients with an acquired disorder. The same surgical procedure was used for all patients: alveoli regulation, socket preparation with resorbable oxycellulose dressing, and sutures with separate stitches. Biological glue and celluloid splints were not used. Depending on the severity of the coagulation disorder, factor VIII or concentrated von Willebrand factor or Desmopressine was administered for patients in the first group. If possible, low-molecular-weight heparin replaced oral anticoagulation for patients in the second group. Platelet concentrates were administered for 2 of the patients in the third group.
  
  
  RESULTS
  Postoperative bleeding was noted in 4 patients in the first group, 2 in the second and 2 in the third.
  
  
  CONCLUSIONS
  We have abandoned the use of biological glue and celluloid splints. The rate of bleeding in the first and second group was similar to that reported in the literature. We were unable to find any comparable report for the third group.
authors.affiliation: Service de Stomatologie et Chirurgie Maxillo-Faciale, Hôpital Roger Salengro, bd du Pr J. Leclercq, 59037 Lille Cedex.
authors.forename: E
authors.initials: E
authors.lastname: Szekely
authors.forename: M-M
authors.initials: MM
authors.lastname: Baralle
authors.forename: G
authors.initials: G
authors.lastname: Raoul
authors.forename: A
authors.initials: A
authors.lastname: Marey
authors.forename: J
authors.initials: J
authors.lastname: Ferri
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D000933:Antifibrinolytic Agents / Q000627:therapeutic use; D001778:Blood Coagulation Disorders; D003894:Deamino Arginine Vasopressin / Q000627:therapeutic use; D017742:Dental Care for Chronically Ill; D005169:Factor VIII / Q000627:therapeutic use; D006490:Hemostatics / Q000627:therapeutic use; D006801:Humans; D017713:Platelet Transfusion; D019106:Postoperative Hemorrhage / Q000517:prevention & control*; D012189:Retrospective Studies; D014081:Tooth Extraction; D014148:Tranexamic Acid / Q000627:therapeutic use; D014841:von Willebrand Factor / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D000933:Antifibrinolytic Agents; D006490:Hemostatics; D014841:von Willebrand Factor; D014148:Tranexamic Acid; D005169:Factor VIII; D003894:Deamino Arginine Vasopressin